Zinplava Prices, Coupons, Copay Cards & Patient Assistance
Zinplava (bezlotoxumab) is a member of the immune globulins drug class and is commonly used for Prevention of Recurrent Clostridioides difficile Infection.
The cost for Zinplava (25 mg/mL) intravenous solution is around $4,011 for a supply of 40 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Zinplava prices
Intravenous Solution
25 mg/mL
Zinplava intravenous solution
from $4,010.90
for 40 milliliters
Quantity | Per unit | Price |
---|---|---|
40 milliliters | $100.27 | $4,010.90 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Zinplava Coupons, Copay Cards and Rebates
Zinplava offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Zinplava Merck Co-Pay Assistance Program
Eligible commercially insured patients will pay $100 per infusion with a maximum benefit of $3,700 for one vial per calendar year; if 2 vials are required for one infusion then the maximum benefit is $7,500 per calendar year; for additional information contact the program at 877-709-4455.
- Applies to:
- Zinplava
- Number of uses:
- per prescription per calendar year
- Expires
- December 31, 2024
Form more information phone: 877-709-4455 or Visit website
Patient Assistance & Copay Programs for Zinplava
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Merck Access Program for Zinplava
Eligibility requirements:- Determined case by case
- Not disclosed
- Medically appropriate condition/diagnosis
- Must be treated by US licensed healthcare provider
- Patient must sign the enrollment form to give the program permission to access their financial information in order to determine eligibility. Patients in need who appear not to qualify should still call. Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients.
- Zinplava (bezlotoxumab) Injection; IV
More information please phone: 877-709-4455 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
More about Zinplava (bezlotoxumab)
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: immune globulins
- Breastfeeding
- En español